Literature DB >> 10199873

Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.

B Zhang1, S Ye, S M Herrmann, P Eriksson, M de Maat, A Evans, D Arveiler, G Luc, F Cambien, A Hamsten, H Watkins, A M Henney.   

Abstract

BACKGROUND: Gelatinase B, a matrix metalloproteinase that has proteolytic activity against connective tissue proteins, has been suggested to be important in the connective tissue remodeling processes associated with atherogenesis and plaque rupture. This study tested the hypothesis that sequence variation in the promoter region of the gelatinase B gene influences its expression, predisposing individuals carrying certain genetic variants to more severe atherosclerosis. METHODS AND
RESULTS: Single-strand conformation polymorphism analysis was carried out to search the promoter region of the gene encoding gelatinase B for naturally occurring genetic variation. As a result, an unreported common polymorphism was detected, which arose from a cytosine (C) to thymidine (T) transition at position -1562 relative to the start of transcription. Transient transfection experiments and DNA-protein interaction assays indicated that the T allele had a higher promoter activity than the C allele, which appeared to be due to preferential binding of a putative transcription repressor protein to the C allelic promoter. A sample of 584 male patients with myocardial infarction and 645 age-matched male healthy control subjects were genotyped. The allele frequencies were not significantly different between the cases and control subjects. However, in 374 patients with available angiographic data, 26% of those carrying 1 or 2 copies of the T allele had >50% stenosis in 3 coronary arteries, whereas only 15% of C/C homozygotes had triple-vessel disease.
CONCLUSIONS: These data suggest that this functional genetic variation influences gelatinase B gene promoter activity in an allele-specific manner and has an effect on atherosclerotic phenotype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10199873     DOI: 10.1161/01.cir.99.14.1788

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  151 in total

Review 1.  The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: insights from genetic studies.

Authors:  A Luttun; M Dewerchin; D Collen; P Carmeliet
Journal:  Curr Atheroscler Rep       Date:  2000-09       Impact factor: 5.113

Review 2.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

3.  Synergistic effects of TIMP2-418G/C and MMP9-1562C/T variants on the male infertility risk.

Authors:  Shiva Roshankhah; Kamran Mansouri; Mitra Bakhtiari; Mohammad Reza Salahshoor; Rezvan Asgari
Journal:  Mol Biol Rep       Date:  2018-12-04       Impact factor: 2.316

4.  The E2 protein of human papillomavirus type 8 increases the expression of matrix metalloproteinase-9 in human keratinocytes and organotypic skin cultures.

Authors:  Baki Akgül; Ramón García-Escudero; Christine Ekechi; Gertrud Steger; Harshad Navsaria; Herbert Pfister; Alan Storey
Journal:  Med Microbiol Immunol       Date:  2011-01-28       Impact factor: 3.402

Review 5.  The role of matrix metalloproteinases in atherothrombosis.

Authors:  Daniel F J Ketelhuth; Magnus Bäck
Journal:  Curr Atheroscler Rep       Date:  2011-04       Impact factor: 5.113

Review 6.  Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases.

Authors:  Takayuki Shiomi; Vincent Lemaître; Jeanine D'Armiento; Yasunori Okada
Journal:  Pathol Int       Date:  2010-07       Impact factor: 2.534

7.  MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study.

Authors:  Alicia Beeghly-Fadiel; Wei Lu; Xiao-Ou Shu; Jirong Long; Qiuyin Cai; Yongbin Xiang; Yu-Tang Gao; Wei Zheng
Journal:  Breast Cancer Res Treat       Date:  2010-08-20       Impact factor: 4.872

8.  Cardiovascular Risk and Matrix Metalloproteinase Polymorphisms: Not Just a Simple Substitution.

Authors:  Francis G Spinale; Ashley A Sapp
Journal:  Circ Cardiovasc Genet       Date:  2017-12

9.  Matrix metalloproteinase (MMP)-3 polymorphism in patients with HBV related chronic liver disease.

Authors:  Hyun Phil Shin; Joung Il Lee; Joo-Ho Jung; Sung-Vin Yim; Hyun Jeong Kim; Jae Myung Cha; Jong Beom Park; Kwang Ro Joo; Jae Seok Hwang; Byoung-Kuk Jang
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

Review 10.  Metalloproteinases and plasminogen activators in vessel remodeling.

Authors:  Alex Bobik; Vselovod Tkachuk
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.